🚀 Pharmidex In Silico Drug Discovery – The Complete Pipeline! 🧬💻
February 28, 2025

At Pharmidex, we bring cutting-edge computational, structural, and molecular biology expertise to accelerate drug discovery and development. Whether you know your protein target and need to find a drug or have drug candidates and need to identify their target, our comprehensive in silico pipeline ensures success.

✨ Why Choose Pharmidex?
✅ Gold-standard software for precision modeling
✅ Hit and binding site identification for target validation
✅ Library mining, extraction, and de novo design
✅ 2D & 3D ligand-based modeling for enhanced screening
✅ Pathway exploration and molecular dynamics analysis
✅ X-ray crystallography & Cryo-EM structure refinement

From target determination to lead optimization, we streamline your drug discovery journey with advanced AI-driven solutions and deep scientific expertise.

📽️ Watch our latest video (5/5) showcasing how Pharmidex transforms drug discovery through computational innovation!

📩 Let’s collaborate and push the boundaries of pharmaceutical innovation together!


#DrugDiscovery #Pharmidex #AIinBiotech #MolecularModeling #PharmaceuticalInnovation

February 4, 2026
At Pharmidex , we deliver high-quality LC-MS bioanalysis to support drug development across a wide range of analysis. Our experienced team supports preclinical, translational and clinical studies, providing accurate, reliable data under GLP and GCP to help drive confident decision-making. Learn more about our LC-MS capabilities: https://www.pharmidex.com/Discovery-Bioanalysis
February 2, 2026
Pharmidex offers high-quality Clinical Chemistry services delivering accurate, reliable data to support drug development. Our expert team and robust, quality-driven workflows enable trusted results that help accelerate decision-making and strengthen collaboration with pharma companies, CROs and academic partners. By working together, we support better science and more efficient drug development. 👉 Learn more: https://www.pharmidex.com/Clinical-chemistry
January 29, 2026
Pharmidex is delighted to share that Ash Alavijeh , Head of Operations, will be attending the UK BioIndustry Association (BIA) Annual Gala Dinner at the Roundhouse, London. Ash is looking forward to connecting with pharma and biotech colleagues to explore new collaborations, partnerships, and opportunities, all with the shared goal of advancing drug discovery and development. If you’re attending, feel free to connect with Ash this evening.
More Posts